CLINICAL_TRIALS
trial_result
· 2013-05-03
Clinical Trial Update: Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV) [Phase 2, Phase 3]
Summary
This document reports results from Phase 2 and Phase 3 trials of nitazoxanide for chronic hepatitis C. Results were posted in May 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cairo University | Conditions: Chronic Hepatitis c | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-05-03